Delaware
|
000-50590
|
11-3516358
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
|
●
|
6,072,383
shares of our common stock, par value $0.0001 per share;
and
|
|
●
|
Warrants
to purchase up to 2,125,334 shares of our common stock (the
“Warrants”);
|
(d)
|
Exhibits.
|
Exhibit
Number
|
Description
|
|
1.1
|
Engagement
letter, dated as of October 19, 2009, by and between Rexahn
Pharmaceuticals, Inc. and Rodman & Renshaw, LLC.
|
|
4.1
|
Form
of Warrant.
|
|
5.1
|
Opinion
of Chadbourne & Parke LLP.
|
|
10.1
|
Securities
Purchase Agreement, dated as of October 19, 2009, by and between Rexahn
Pharmaceuticals, Inc. and the purchasers signatory
thereto.
|
|
23.1
|
Consent
of Chadbourne & Parke LLP (included in Exhibit
5.1).
|
|
99.1
|
Press
release dated October 19, 2009.
|
REXAHN
PHARMACEUTICALS, INC.
|
|||
(Registrant)
|
|||
By:
|
/s/ Chang H. Ahn
|
||
Chang
H. Ahn
|
|||
Chairman
and Chief Executive Officer
|
Exhibit
Number
|
Description
|
|
Engagement
letter, dated as of October 19, 2009, by and between Rexahn
Pharmaceuticals, Inc. and Rodman & Renshaw, LLC.
|
||
Form
of Warrant.
|
||
Opinion
of Chadbourne & Parke LLP.
|
||
Securities
Purchase Agreement, dated as of October 19, 2009, by and between Rexahn
Pharmaceuticals, Inc. and the purchasers signatory
thereto.
|
||
23.1
|
Consent
of Chadbourne & Parke LLP (included in Exhibit
5.1).
|
|
Press
release dated October 19, 2009.
|